Company news
Solana Company news in 2025
Solana Company's news releases, calls and decks from 2025, newest first.
Solana Company Reports Third Quarter 2025 Financial Results
November 18, 2025
Solana Company to Release Third Quarter Operating Results on November 18, 2025
November 11, 2025
Solana Company (NASDAQ: HSDT) Releases Investor Update
November 5, 2025
Solana Company Files Application to Cease to Be a Reporting Issuer in Canada
November 3, 2025
CORRECTION – Solana Company Announces Updated SOL Holdings and Industry Leading Staking Yield
October 28, 2025
Solana Company NASDAQHSDT Selects BitGo as Custodian for SOL Treasury Holdings
October 13, 2025
Solana Company (NASDAQ: HSDT) Selects BitGo as Custodian for SOL Treasury Holdings
October 10, 2025
Solana Company (NASDAQ: HSDT), Formerly Helius, Continues Amassing SOL, the Native Asset of Solana Blockchain
October 6, 2025
Helius Announces FDA 510(k) Submission for PoNS® Device Label Expansion in Stroke
September 24, 2025
Helius (NASDAQ: HSDT), in Partnership with Pantera Capital and Summer Capital Closes Over $500 Million Private Placement to Launch SOL Treasury Company
September 17, 2025
Helius (NASDAQ: HSDT), in Partnership with Pantera Capital and Summer Capital Announces Over $500 Million in Funding to Launch SOL Treasury Company
September 14, 2025
Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation
July 20, 2025
Helius Medical Technologies, Inc. Compliant with Nasdaq’s Continued Listing Requirements
July 8, 2025
Helius Medical Technologies Announces Reverse Stock Split
June 26, 2025
Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device
June 15, 2025
Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting
June 11, 2025
Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device
June 10, 2025
Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria
June 3, 2025
Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering
June 3, 2025
Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual Meeting
May 19, 2025
Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
May 11, 2025
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary
March 12, 2025
Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
March 10, 2025
Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study
January 21, 2025
Helius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial Target
January 20, 2025
Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market
January 20, 2025
Calls in 2025
Decks in 2025
- Investor Presentation (November 2025)
Investor deck · 25 slides · Nov 3, 2025
- Helius Medical Technologies — Investor Presentation (September 2025)
Investor deck · 23 slides · Sep 15, 2025